Tag: remdesivir
COVID-19 fighter remdesivir racks up $873M as Gilead plays defense on...
Gilead Sciences started charging for remdesivir in July. Given its status then as the only drug authorized for COVID-19 in the U.S., industry watchers...
Eli Lilly’s Olumiant pares COVID-19 patients’ recovery time down to 7...
Months into the COVID-19 pandemic, just two therapies have emerged as FDA-approved emergency therapies for hospitalized patients. Last month, Eli Lilly rolled out findings...
Gilead’s COVID med remdesivir is scarce and costly, AGs say, urging...
Unhappy with the price and availability of Gilead’s remdesivir—the only drug with FDA clearance to treat COVID-19—dozens of state attorney generals have called for the federal government to exercise march-in...
Remdesivir stockpiling could help push COVID drug into profitable territory for...
Ever since the FDA last month cleared Gilead’s remdesivir for emergency use to treat COVID-19, investors have been wondering if the drug could possibly...
Early missteps, transparency questions dog U.S. government’s remdesivir rollout: reports
When there’s only one proven therapy for a global pandemic that’s infected millions—and a limited initial supply—how exactly should officials distribute it? So far, the U.S. government...
